Founded in Milan in May 2004, the Association works in applied clinical research and puts the goals of:
Promote the use of G.C.P. (Good Clinical Practice) in clinical trials and relevant regulations ( GLP, GMP, etc. ) and national and international guidelines, where applicable, regardless of registration of the drug tested.
Ensuring quality standards in the practice of our members.
Represent the common positions of members on matters relating to clinical research before regulatory authorities both nationally and internationally.
Collaborate with other authorities and / or recognized Orders and Associations in order to further develop clinical research, particularly taking into account the safety of the drug.
Promote training for staff involved in clinical research.
Provide accurate information about clinical research through the media.
Contact
Piazza Meda, 3
20121 Milano
Segreteria
Cell. 393 3516898
dal lunedì al venerdì
dalle 9.30 alle 12.30
Over more than 25 years, PAREXEL has expanded its global footprint through a combination of organic growth, alliances, and acquisitions. What was the rationale behind entering Italy in 1995 and…
Roche Italy is one of the companies which went through the most significant re-organization process in the country in the past three years- with important changes in both its marketing…
When you were appointed General Director of the Agenzia Italiana del Farmaco (AIFA) in 2007, the dedicated Investigation Commission highlighted the need for an in-depth reorganization of the Agency in…
When you became President of Sankyo Pharma Italy in 2003 one of your objectives was to maximize sales of the existing portfolio- and the company’s sales have impressively tripled in…
Intermediate distribution plays a crucial role in establishing bridges between industrial production and final delivery to patients- and in Italy, this function is executed with highly contained costs and commercial…
You have led a successful career within the Solvay Group in various European countries. Looking back at all these international assignments, including you current function of regional Director South Europe,…
Biotechnologies have a significant role to play bringing Italy towards a more knowledge-based economy. What is the economic contribution of the sector today? According to the last Blossom Associati-Assobiotec report…
After long experience in the pharmaceutical industry, working in both multinational and local laboratories, you took the reins of the already well-established Italian subsidiary of Ferring a few months ago.…
Dr Fazi, you co-founded Eurogroup Consulting (EGC) in Italy in 2007 and are now leading a well established reality, renowned for the new model of governance it has designed. Could…
Following the successful result of the “Piano Sanitario Nazionale” 2005 – 2008, could you introduce to ours readers the key priorities and main health policies to be implemented by 2009…
Following 20 years of a comprehensive experience in diverse fields of the pharmaceutical industry, you entered Baxter in 2000. At the time, the Italian affiliate was already a well established…
Despite Italy being one of the most important pharmaceutical markets not only in Europe but also in the World, the industry remained quite stable for the last two years and…
See our Cookie Privacy Policy Here
